Yüklüyor......
Rationale for the Radiation Therapy Oncology Group Study RTOG P-0014
Chemotherapy currently has an established role in the treatment of hormonerefractory prostate cancer. There is strong evidence that combined-modality treatment, using androgen ablation in addition to radiotherapy, provides a benefit above and beyond radiotherapy alone in patients with a poor prognos...
Kaydedildi:
| Asıl Yazarlar: | , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
MedReviews, LLC
2003
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1502335/ https://ncbi.nlm.nih.gov/pubmed/16986043 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|